Australia markets open in 5 hours 52 minutes

Gaush Meditech Ltd (2407.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
19.500-0.480 (-2.40%)
At close: 04:08PM HKT

Gaush Meditech Ltd

Building A, Zhonghui Plaza
Room 1901 No.11 Dongzhimen South Avenue Dongcheng District
Beijing
China
86 010 5978 6328
https://www.gaush.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees869

Key executives

NameTitlePayExercisedYear born
Mr. Tieta GaoExecutive Chairman1.39MN/A1965
Mr. Xinwei LiuExecutive Director & CEO1.2MN/A1982
Mr. Jianjun ZhangHonorary President & Executive Director882.01kN/A1964
Ms. Wenqi LiCFO & Executive Director885.26kN/A1974
Dr. Aleksey Nikolaevich SimonovChief Technology Officer2.12MN/A1972
Mr. Xinli ZhaoExecutive Director & Chief Compliance Officer1.14MN/A1967
Ms. Shui Bing Leung A.C.S.Joint Company SecretaryN/AN/A1977
Mr. Bo ZhangJoint Company SecretaryN/AN/A1986
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People's Republic of China, the Asia Pacific, Germany, Europe, the Americas, Oceania, and internationally. The company operates through four segments: Proprietary Products, Distribution Products, Technical Services, and Others. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, and ophthalmic disease diagnosis and treatment equipment and related supporting consumables. The Distribution Products segment sells diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment, and related supporting consumables. The Technical Services segment provides warranty services, maintenance services, and after-sales services related consumables. The Others segment provides services related to clinical research organization, and licenses intellectual properties. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology. The company also provides technical services, that includes repair and maintenance services. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Corporate governance

Gaush Meditech Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.